Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Bartley

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Medical Journal of Australia|November 13, 1971
Landry-Guillain-Barre syndrome in infectious mononucleosis. Unusual nerve findingsP C Bartley
The Australasian Journal of Dermatology|December 1, 1978
Topical steroids and hypothalamo-pituitary-adrenal suppression: a reviewP C Bartley
Australian and New Zealand Journal of Medicine|April 1, 1973
Pulmonary candidiasis treated with 5-fluorocytosineP C Bartley
The Medical Journal of Australia|May 13, 1972
Phenformin-induced lactic acidosis in diabetes mellitusS Bryant, P C Bartley
Australian and New Zealand Journal of Medicine|February 1, 1979
Haemoglobin A1 in diabetes mellitusP C Bartley, T E Hambling
The Medical Journal of Australia|January 1, 1996
The diabetes epidemic in Australia: prevalence, patterns and the public healthJ N Carter, P C Bartley
Australian and New Zealand Journal of Medicine|February 1, 1975
Urinary cyclic AMP in diagnosis and management of hypercalcaemia: studies of patients without primary hyperparathyroidismP C Bartley, H M Lloyd, D Willgoss
Australian and New Zealand Journal of Medicine|February 1, 1975
Urinary excretion of cyclic AMP in primary hyperparathyroidismP C Bartley, D Willgoss, H M Lloyd
The Medical Journal of Australia|July 31, 1976
Medullary carcinoma of the thyroid, multiple phaeochromocytomas, mucosal neuromas, marfanoid habitus and other abnormalities (Sipple's syndrome)P C Bartley, H M Lloyd, R E Aitken
Diabetic Medicine : a Journal of the British Diabetic Association|April 5, 2008
Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trialP C Bartley, M Bogoev, J Larsen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Medical Journal of Australia|November 13, 1971
Landry-Guillain-Barre syndrome in infectious mononucleosis. Unusual nerve findingsP C Bartley
The Australasian Journal of Dermatology|December 1, 1978
Topical steroids and hypothalamo-pituitary-adrenal suppression: a reviewP C Bartley
Australian and New Zealand Journal of Medicine|April 1, 1973
Pulmonary candidiasis treated with 5-fluorocytosineP C Bartley
The Medical Journal of Australia|May 13, 1972
Phenformin-induced lactic acidosis in diabetes mellitusS Bryant, P C Bartley
Australian and New Zealand Journal of Medicine|February 1, 1979
Haemoglobin A1 in diabetes mellitusP C Bartley, T E Hambling
The Medical Journal of Australia|January 1, 1996
The diabetes epidemic in Australia: prevalence, patterns and the public healthJ N Carter, P C Bartley
Australian and New Zealand Journal of Medicine|February 1, 1975
Urinary cyclic AMP in diagnosis and management of hypercalcaemia: studies of patients without primary hyperparathyroidismP C Bartley, H M Lloyd, D Willgoss
Australian and New Zealand Journal of Medicine|February 1, 1975
Urinary excretion of cyclic AMP in primary hyperparathyroidismP C Bartley, D Willgoss, H M Lloyd
The Medical Journal of Australia|July 31, 1976
Medullary carcinoma of the thyroid, multiple phaeochromocytomas, mucosal neuromas, marfanoid habitus and other abnormalities (Sipple's syndrome)P C Bartley, H M Lloyd, R E Aitken
Diabetic Medicine : a Journal of the British Diabetic Association|April 5, 2008
Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trialP C Bartley, M Bogoev, J Larsen, et al.
Pageof 2